Assertio Holdings Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| AZN | AstraZeneca PLC | Outperform |
17
|
£120.50 | £165.99 | 35.23% | 16 | £186.80B |
| AMGN | Amgen | Outperform |
4
|
$311.29 | $303.65 | 2.80% | 8 | $166.99B |
| PFE | Pfizer | Outperform |
2
|
$27.81 | $32.87 | 9.67% | 6 | $157.48B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$64.78 | $87.82 | 23.49% | 14 | $80.78B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥5.50k | ¥5.24k | 5.42% | 0 | ¥10.55T |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | ¥4.74k | 10.30% | 0 | ¥6.47T |
| JAZZ | Jazz Pharmaceuticals | Outperform |
14
|
$110.01 | $188.32 | 70.89% | 4 | $6.88B |
| HLUN A | H. Lundbeck A/S | Outperform |
18
|
kr33.50 | kr190.00 | 8.96% | 6 | kr32.86B |
| INSM | Insmed | Buy |
11
|
$25.55 | $41.42 | 64.38% | 8 | $3.80B |
| PBH | Prestige Consumer Healthcare | Outperform |
16
|
$70.00 | $71.50 | 6.43% | 3 | $3.48B |
| BHC | Bausch Health Companies | Hold |
15
|
$7.82 | $9.50 | 21.48% | 5 | $3.21B |
| AMPH | Amphastar Pharmaceuticals | Outperform |
14
|
$42.46 | $69.00 | 46.02% | 0 | $2.02B |
| SUPN | Supernus Pharmaceuticals | Outperform |
16
|
$30.83 | $41.00 | 29.74% | 0 | $1.69B |
| ANIP | ANI Pharmaceuticals | Buy |
13
|
$67.25 | $69.75 | 18.96% | 1 | $1.38B |
| IRWD | Ironwood Pharmaceuticals | Buy |
14
|
$8.12 | $17.83 | 109.36% | 2 | $1.29B |
| COPN | Cosmo Pharmaceuticals N.V. | Buy |
12
|
CHF72.20 | CHF76.55 | 29.58% | 0 | CHF1.16B |
| PCRX | Pacira BioSciences | Outperform |
16
|
$27.21 | $47.90 | 65.38% | 6 | $1.27B |
| COLL | Collegium Pharmaceutical | Outperform |
11
|
$37.51 | $37.75 | 6.64% | 1 | $1.23B |
| AQST | Aquestive Therapeutics | Buy |
0
|
$3.52 | $6.33 | 155.68% | 0 | $298.61M |
| CHRS | Coherus BioSciences | Outperform |
6
|
$2.27 | $10.86 | 252.42% | 3 | $222.46M |
| ABEO | Abeona Therapeutics | Buy |
8
|
$4.60 | $21.25 | 269.57% | 2 | $207.08M |
| NKTR | Nektar Therapeutics | Hold |
11
|
$1.57 | $2.75 | -36.31% | 2 | $171.69M |
| EBS | Emergent BioSolutions | Outperform |
16
|
$3.89 | $5.00 | 28.53% | 0 | $101.11M |
| DRRX | DURECT | Outperform |
9
|
$1.16 | $6.75 | 481.90% | 2 | $36.00M |
| ALVIO | Valerio Therapeutics Société... | - |
8
|
0.13€ | 1.30€ | 15.38% | 0 | 26.19€M |
| ACOR | Acorda Therapeutics | - |
5
|
$0.43 | $200.00 | -100.00% | 1 | $15.89M |
| ENZN | Enzon Pharmaceuticals | - |
0
|
$0.09 | $16.00 | -100.00% | 0 | $8.48M |
| DMK | DMK Pharmaceuticals | - |
8
|
$0.05 | $1.50 | -100.00% | 0 | $0.35M |